Healthcare Services

Allergy Immunotherapy Market: Trends, Drivers, and Opportunities

April 17, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Allergy Immunotherapy Market Progress Between 2026 And 2030?

The allergy immunotherapy market size has experienced rapid expansion in recent years. It is forecast to increase from $3.16 billion in 2025 to $3.55 billion in 2026, at a compound annual growth rate (CAGR) of 12.3%. The growth observed in the historic period is attributable to limited awareness about allergy immunotherapy, a rising incidence of seasonal allergic rhinitis, dependency on hospital-based treatment channels, the adoption of traditional treatment methods, and regulatory approvals for immunotherapy products.

The allergy immunotherapy market is projected for substantial expansion over the next few years. It is forecast to achieve a valuation of $5.64 billion by 2030, progressing at a compound annual growth rate (CAGR) of 12.2%. This anticipated growth is influenced by several factors, including the proliferation of personalized immunotherapy solutions, the increasing use of online pharmacy channels, the expansion of pediatric allergy treatment options, a surge in investment dedicated to immunotherapy research, and the ongoing development of combination immunotherapy products. Prominent trends for the forecast duration encompass the growing acceptance of subcutaneous and sublingual immunotherapy, an escalating incidence of allergic rhinitis and asthma, the broadening scope of food and venom allergy treatments, an enhanced focus on tailored allergy treatment protocols, and improved awareness leading to earlier diagnosis of allergic conditions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Which Primary Drivers Are Impacting The Allergy Immunotherapy Market Growth?

The increasing incidence of allergic disorders is projected to fuel the expansion of the allergy immunotherapy market moving forward. Allergic disorders are defined as exaggerated immune responses to specific antigens, distinct from autoimmune diseases where immune responses are mistakenly directed against the body’s own components. Allergy immunotherapy is available for atopic individuals who suffer from conditions such as IgE-mediated allergic rhinitis and allergic asthma, triggered by inhaled allergens including pollens and house dust mites (HDMs). For example, in August 2023, the Medicines and Healthcare Products Regulatory Agency (MHRA), a UK-based executive agency, reported that English hospitals recorded over 25,000 admissions for allergies and anaphylaxis in 2022-23, a figure more than double that seen in the last twenty years. Additionally, in May 2024, the Food Standards Agency, a UK-based government department, published its Patterns and Prevalence of Adult Food Allergy (PAFA) report, revealing that around 6% of adults in the UK, approximately 2.4 million individuals, are affected by food allergies. Hence, the growing prevalence of allergic disorders is a key factor driving the growth of the allergy immunotherapy market.

How Is The Allergy Immunotherapy Market Organized By Segment Classification?

The allergy immunotherapy market covered in this report is segmented –

1) By Allergy Type: Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, Allergic Conjunctivitis, Environmental Allergies

2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)

3) By Channel: Hospital Pharmacy, Retail Pharmacy

Subsegments:

1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis

2) By Allergic Asthma: House Dust Mite–Induced Allergic Asthma, Pollen-Induced Allergic Asthma, Animal Dander–Induced Allergic Asthma

3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies

4) By Venom Allergy: Bee Venom Allergy, Wasp Venom Allergy, Hornet Venom Allergy, Other Insect Venom Allergies

5) By Allergic Conjunctivitis: Seasonal Allergic Conjunctivitis, Perennial Allergic Conjunctivitis

6) By Environmental Allergies: House Dust Mite Allergy, Pollen Allergy, Mold Allergy, Animal Dander Allergy

Which Trends Are Shaping Growth In The Allergy Immunotherapy Market?

Major companies operating within the allergy immunotherapy market are innovating technological products, such as artificial intelligence (AI)-powered allergy component testing, to sustain their market position. This AI-powered allergy component testing is a novel diagnostic platform rooted in component resolved diagnostics (CRD) designed for diagnosing diverse forms of allergies. As an example, in May 2023, Metropolis Healthcare Limited, an Indian-based Medical laboratory company, launched its artificial intelligence (AI)-powered allergy component testing. This innovative fourth-generation allergy testing technology utilizes Artificial Intelligence (AI) to assist clinicians in their clinical decision-making. It offers significant insights for selecting and optimizing the treatment course for allergic diseases. Moreover, it can predict the effectiveness of immunotherapy for allergy vaccinations, indicating their potential success.

Who Are The Industry Participants Involved In The Allergy Immunotherapy Market?

Major companies operating in the allergy immunotherapy market are LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Mylan N.V., Adamis Pharmaceuticals Corporation, Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.

Get The Full Allergy Immunotherapy Market Report:

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Which Region Dominates The Allergy Immunotherapy Market By Market Share?

Europe was the largest region in the allergy immunotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Allergy Immunotherapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Browse Through More Reports Similar to the Global Allergy Immunotherapy Market 2026, By The Business Research Company

Cellulars Immunotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Allergy Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report

Allergy Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795